Joint of Pediatrics, Johns Hopkins University School of Medicine
Radiology
Dr. Ruth Karron, MD
|
|
Give Review
Ruth Karron works in the field of Radiology. She went to medical school at NYU School of Medicine. Ruth Karron is also published. She has 80 publications published. The lastest publication: "Addition of a missense mutation present in the L gene of respiratory syncytial virus (RSV) cpts530/1030 to RSV vaccine candidate cpts248/404 increases its attenuation ...'
Publications
- Evaluation of a Live-Attenuated Human Parainfluenza Type 1 Vaccine in Adults and Children.
- A gene deletion that up-regulates viral gene expression yields an attenuated RSV vaccine with improved antibody responses in children.
- Efficacy of motavizumab for the prevention of respiratory syncytial virus disease in healthy Native American infants: a phase 3 randomised double-blind placebo-control...
- Impact of placental malaria and hypergammaglobulinemia on transplacental transfer of respiratory syncytial virus antibody in Papua New Guinea.
- Parainfluenza virus type 3 Ab in allogeneic hematopoietic cell transplant recipients: factors influencing post-transplant Ab titers and associated outcomes.
- A live attenuated H5N1 vaccine induces long-term immunity in the absence of a primary antibody response.
- Safety and infectivity of two doses of live-attenuated recombinant cold-passaged human parainfluenza type 3 virus vaccine rHPIV3cp45 in HPIV3-seronegative young children.
- Experimental Infection Of Adults With Recombinant Wild-Type Human Metapneumovirus (rHMPV-SHs).
- Attenuation of live respiratory syncytial virus vaccines is associated with reductions in levels of nasal cytokines.
- A Prospective Study of Agents Associated with Acute Respiratory Infection among Young American Indian Children.
- An open-label phase I trial of a live attenuated H2N2 influenza virus vaccine in healthy adults.
- Live-attenuated respiratory syncytial virus vaccines.
- The Obligation to Prevent the Next Dual-Use Controversy.
- Immune Response Following H1N1pdm09 Vaccination: Differences in Antibody Repertoire and Avidity in Young Adults and Elderly Populations Stratified by Age and Gender.
- Progress in the development of human parainfluenza virus vaccines.
- The cDNA-derived investigational human parainfluenza virus type 3 vaccine rcp45 is well tolerated, infectious, and immunogenic in infants and young children.
- An open label Phase I trial of a live attenuated H6N1 influenza virus vaccine in healthy adults.
- A single dose of unadjuvanted novel 2009 H1N1 vaccine is immunogenic and well tolerated in young and elderly adults.
- Breathing new life into pneumonia diagnostics.
- Evaluation of two live attenuated cold-adapted H5N1 influenza virus vaccines in healthy adults.
- A live attenuated H7N3 influenza virus vaccine is well tolerated and immunogenic in a Phase I trial in healthy adults.
- A live attenuated H9N2 influenza vaccine is well tolerated and immunogenic in healthy adults.
- Young infants can develop protective levels of neutralizing antibody after infection with respiratory syncytial virus.
- The role of neutralizing antibodies in protection of American Indian infants against respiratory syncytial virus disease.
- The absence of enhanced disease with wild type respiratory syncytial virus infection occurring after receipt of live, attenuated, respiratory syncytial virus vaccines.
- Social justice and disadvantaged groups.
- Comparison of results of detection of rhinovirus by PCR and viral culture in human nasal wash specimens from subjects with and without clinical symptoms of respiratory...
- A global pandemic influenza vaccine action plan.
- C5 modulates airway hyperreactivity and pulmonary eosinophilia during enhanced respiratory syncytial virus disease by decreasing C3a receptor expression.
- The impact of infection with human metapneumovirus and other respiratory viruses in young infants and children at high risk for severe pulmonary disease.
- The interferon antagonist NS2 protein of respiratory syncytial virus is an important virulence determinant for humans.
- Transmissibility, infectivity and immunogenicity of a live human parainfluenza type 3 virus vaccine (HPIV3cp45) among susceptible infants and toddlers.
- The cysteine-rich region of respiratory syncytial virus attachment protein inhibits innate immunity elicited by the virus and endotoxin.
- A bovine parainfluenza virus type 3 vaccine is safe and immunogenic in early infancy.
- Identification of a recombinant live attenuated respiratory syncytial virus vaccine candidate that is highly attenuated in infants.
- rDEN4delta30, a live attenuated dengue virus type 4 vaccine candidate, is safe, immunogenic, and highly infectious in healthy adult volunteers.
- Evaluation of combined live, attenuated respiratory syncytial virus and parainfluenza 3 virus vaccines in infants and young children.
- Anti-G protein antibody responses to respiratory syncytial virus infection or vaccination are associated with inhibition of G protein CX3C-CX3CR1 binding and leukocyte...
- Differential production of inflammatory cytokines in primary infection with human metapneumovirus and with other common respiratory viruses of infancy.
- Phase 2 evaluation of parainfluenza type 3 cold passage mutant 45 live attenuated vaccine in healthy children 6-18 months old.
- The future of respiratory syncytial virus vaccine development.
- Progress in the development of respiratory syncytial virus and parainfluenza virus vaccines.
- A live human parainfluenza type 3 virus vaccine is attenuated and immunogenic in young infants.
- A role for immune complexes in enhanced respiratory syncytial virus disease.
- Comparison of temple temperatures with rectal temperatures in children under two years of age.
- Respiratory syncytial virus infection in Navajo and White Mountain Apache children.
- Multiplex assay for detection of strain-specific antibodies against the two variable regions of the G protein of respiratory syncytial virus.
- Risk factors for severe respiratory syncytial virus infection among Alaska native children.
- Clinical evaluation of a single oral dose of human-bovine (UK) reassortant rotavirus vaccines Wa x UK (P1A[8],G6) and Wa x (DS-1 x UK) (P1A[8],G2).
- A live attenuated recombinant dengue-4 virus vaccine candidate with restricted capacity for dissemination in mosquitoes and lack of transmission from vaccinees to mosq...
- Attenuation and immunogenicity in humans of a live dengue virus type-4 vaccine candidate with a 30 nucleotide deletion in its 3'-untranslated region.
- Severe respiratory syncytial virus disease in Alaska native children. RSV Alaska Study Group.
- RSV-associated hospitalizations in Alaska Native infants.
- Addition of a missense mutation present in the L gene of respiratory syncytial virus (RSV) cpts530/1030 to RSV vaccine candidate cpts248/404 increases its attenuation ...
- Respiratory syncytial virus vaccines.
- Evaluation of two live, cold-passaged, temperature-sensitive respiratory syncytial virus vaccines in chimpanzees and in human adults, infants, and children.
- Respiratory syncytial virus (RSV) SH and G proteins are not essential for viral replication in vitro: clinical evaluation and molecular characterization of a cold-pass...
- Evaluation of a live attenuated bovine parainfluenza type 3 vaccine in two- to six-month-old infants.
- Effective immunization with live attenuated influenza A virus can be achieved in early infancy. Pediatric Care Center.
- Effect of heterosubtypic immunity on infection with attenuated influenza A virus vaccines in young children.
- Safety and immunogenicity of a recombinant protein influenza A vaccine in adult human volunteers and protective efficacy against wild-type H1N1 virus challenge.
- Molecular epidemiology of a parainfluenza type 3 virus outbreak on a pediatric ward.
- Use of PCR-enzyme immunoassay for identification of influenza A virus matrix RNA in clinical samples negative for cultivable virus.
- Rapid detection of parainfluenza virus type 3 RNA in respiratory specimens: use of reverse transcription-PCR-enzyme immunoassay.
- An update on approaches to the development of respiratory syncytial virus (RSV) and parainfluenza virus type 3 (PIV3) vaccines.
- A live attenuated bovine parainfluenza virus type 3 vaccine is safe, infectious, immunogenic, and phenotypically stable in infants and children.
- Safety and immunogenicity of a cold-adapted influenza A (H1N1) reassortant virus vaccine administered to infants less than six months of age.
- A live human parainfluenza type 3 virus vaccine is attenuated and immunogenic in healthy infants and children.
- Studies of prototype live hepatitis A virus vaccines in primate models.
- An outbreak of hepatitis A among cancer patients treated with interleukin-2 and lymphokine-activated killer cells.
- Use of single-gene reassortant viruses to study the role of avian influenza A virus genes in attenuation of wild-type human influenza A virus for squirrel monkeys and ...
- Evaluation of a live attenuated, cold-adapted parainfluenza virus type 3 vaccine in children.
- Safety and immunogenicity trial in adult volunteers of a human papillomavirus 16 L1 virus-like particle vaccine.
- Influenza: a pediatrician's perspective.
- Evaluation of a live, cold-passaged, temperature-sensitive, respiratory syncytial virus vaccine candidate in infancy.
- Evaluation of the live attenuated cpts 248/404 RSV vaccine in combination with a subunit RSV vaccine (PFP-2) in healthy young and older adults.
- Safety and immunogenicity of live attenuated human-bovine (UK) reassortant rotavirus vaccines with VP7-specificity for serotypes 1, 2, 3 or 4 in adults, children and i...
- Safety and immunogenicity of human rotavirus vaccine strain M37 in adults, children, and infants.
- Safety and immunogenicity of live attenuated quadrivalent human-bovine (UK) reassortant rotavirus vaccine administered with childhood vaccines to infants.
Schools
New York University
Doctors Specialties
- Pediatric Infectious Disease Medicine
- Radiology
Accepted Insurances
Education
-
Johns Hopkins University -
National Institutes of Health Clinical Center -
Children's National Medical Center - George Washington University -
NYU School of Medicine
Helpful Reviews
Similar Doctors
|
|
Dr. Gaurav Jindal, MD
 This Doctor is OpenDoctor Recommended.
|
|
|
Dr. Andrea A. Berry, MD
This Doctor is OpenDoctor Recommended.
|
|
|
Dr. Susan V. Lipton, MD
This Doctor is OpenDoctor Recommended.
|
|
|
Dr. Stephanie Terezakis, MD
This Doctor is OpenDoctor Recommended.
|
|
|
Dr. Katherine L. O'Brien, MD
This Doctor is OpenDoctor Recommended.
 This doctor has more publications
|
|
|
Dr. Jakub K. Simon, MD
This Doctor is OpenDoctor Recommended.
|
|
|
Dr. Stuart E. Mirvis, MD
This Doctor is OpenDoctor Recommended.
|
|
|
Dr. Ronald J. Stanfield, MD
This Doctor is OpenDoctor Recommended.
|
|
|
Dr. Andrea J. Ruff, MD
This Doctor is OpenDoctor Recommended.
|
|
|
Dr. Matthew B. Laurens, MD
This Doctor is OpenDoctor Recommended.
|
|
|
Dr. Anmoldeep S. Bajaj, MD |
|
|
Dr. Richard N. Pierson, MD
This Doctor is OpenDoctor Recommended.
|
|
|
Dr. Anna A. Minta, MD
This Doctor is OpenDoctor Recommended.
|
|
|
Dr. William J. Moss, MD |
|
|
Dr. Jitka Sojkova, MD
This Doctor is OpenDoctor Recommended.
|